Thu, April 2, 2020

David Risinger Maintained (AMRX) at Hold with Decreased Target to $3 on, Apr 2nd, 2020

David Risinger of Morgan Stanley, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Decreased Target from $5 to $3 on, Apr 2nd, 2020.

David has made no other calls on AMRX in the last 4 months.



There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Maintained at Hold with Increased Target to $4 on, Thursday, January 2nd, 2020